Aclaris Therapeutics
ACRS
#7748
Rank
โ‚ฌ0.29 B
Marketcap
2,76ย โ‚ฌ
Share price
-2.13%
Change (1 day)
-25.47%
Change (1 year)

Revenue for Aclaris Therapeutics (ACRS)

Revenue in 2025 (TTM): โ‚ฌ14.51 Million

According to Aclaris Therapeutics's latest financial reports the company's current revenue (TTM ) is โ‚ฌ13.53 Million. In 2024 the company made a revenue of โ‚ฌ17.99 Million a decrease over the revenue in the year 2023 that were of โ‚ฌ28.26 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Aclaris Therapeutics from 2015 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚ฌ14.51 M-19.32%
2024 โ‚ฌ17.99 M-36.36%
2023 โ‚ฌ28.26 M1.92%
2022 โ‚ฌ27.73 M364.6%
2021 โ‚ฌ5.96 M13.28%
2020 โ‚ฌ5.26 M39.66%
2019 โ‚ฌ3.77 M-54.95%
2018 โ‚ฌ8.37 M497.08%
2017 โ‚ฌ1.4 M
2016 N/A
2015 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ORIC Pharmaceuticals
ORIC
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA